tm logo
DEFENCE THERAPEUTICS ACCUTOX
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 12 Nov 2024

Last Applicant/ Owned by

200 Burrard Street, Suite 1680

Vancouver (BC)

CA

V6C3L6

Serial Number

98147291 filed on 23rd Aug 2023

Registration Number

N/A

Correspondent Address

Joel Karni Schmidt

Joel Karni Schmidt COWAN, LIEBOWITZ & LATMAN, P.C.

NEW YORK, NY 10036-1525

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

DEFENCE THERAPEUTICS ACCUTOX

Research and development of vaccines and medicines Vaccines for human use; medicinal preparations for use in oncology; drug delivery agent consisting of intracellular enhancers in the nature of compounds that facilitates delivery of a wide range of pharmaceuticals

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development of vaccines and medicines


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Vaccines for human use; medicinal preparations for use in oncology; drug delivery agent consisting of intracellular enhancers in the nature of compounds that facilitates delivery of a wide range of pharmaceuticals


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 98147291

Mark Type

No Service Mark

Attorney Docket Number

No 32900.03/JKS

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
12th Nov 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17th Sep 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17th Sep 2024PUBLISHED FOR OPPOSITION
28th Aug 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09th Aug 2024APPROVED FOR PUB - PRINCIPAL REGISTER
03rd Jul 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
03rd Jul 2024TEAS/EMAIL CORRESPONDENCE ENTERED
03rd Jul 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
25th Apr 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
25th Apr 2024NON-FINAL ACTION E-MAILED